General Information of Drug (ID:
DR0138) |
Drug Name |
Arotinolol
|
Synonyms |
Arotinolol; Arotinolol (INN); Arotinolol [INN]; Arotinololum; Arotinololum [Latin]; (+-)-5-(2-((3-(tert-Butylamino)-2-hydroxypropyl)thio)-4-thiazolyl)-2-thiophenecarboxamide; 2-(3-tert-Butylamino-2-hydroxypropylthio)-4-(5-carbamoyl-2-thienyl)thiazole; 5-(2-((3-(tert-Butylamino)-2-hydroxypropyl)thio)thiazol-4-yl)thiophene-2-carboxamide; 5-[2-[3-(tert-butylamino)-2-hydroxypropyl]sulfanyl-1,3-thiazol-4-yl]thiophene-2-carboxamide; 68377-92-4; AK129719; C15H21N3O2S3; S-596
|
Indication |
Essential tremor
[ICD11: 8A04]
|
Phase 4
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
371.5 |
Topological Polar Surface Area |
170 |
Heavy Atom Count |
23 |
Rotatable Bond Count |
8 |
Hydrogen Bond Donor Count |
3 |
Hydrogen Bond Acceptor Count |
7 |
Cross-matching ID |
- PubChem CID
- 2239
- ChEBI ID
-
- CAS Number
-
- Formula
- C15H21N3O2S3
- Canonical SMILES
- CC(C)(C)NCC(CSC1=NC(=CS1)C2=CC=C(S2)C(=O)N)O
- InChI
- 1S/C15H21N3O2S3/c1-15(2,3)17-6-9(19)7-21-14-18-10(8-22-14)11-4-5-12(23-11)13(16)20/h4-5,8-9,17,19H,6-7H2,1-3H3,(H2,16,20)
- InChIKey
- BHIAIPWSVYSKJS-UHFFFAOYSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.